| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/26/2009 | US20090053788 Muscular dystrophy drug |
| 02/26/2009 | US20090053784 Expression of an active carrier from xylose in genetically modified saccharomyces cerevisae |
| 02/26/2009 | US20090053783 3-hydroxypropionic acid and other organic compounds |
| 02/26/2009 | US20090053779 Mutant microorganism having improved production ability of branched amino acid and method for preparing branched amino acid using the same |
| 02/26/2009 | US20090053766 Methods and compositions for producing recombinant proteins using a gene for trna |
| 02/26/2009 | US20090053765 Variants of Beta-Glucosidase |
| 02/26/2009 | US20090053764 Salutaridinol 7-0-Acetyltransferase and Derivatives Thereof |
| 02/26/2009 | US20090053763 Tumor endothelial marker 7-alpha molecules and uses thereof |
| 02/26/2009 | US20090053761 Polypeptide Mutagenesis Method |
| 02/26/2009 | US20090053748 Cytochrome c protein and assay |
| 02/26/2009 | US20090053735 Vector expressing n-deacetylase/n-sulfotransferase 2 |
| 02/26/2009 | US20090053730 Chimeric human t1r1 taste receptor polypeptides and compositions containing same |
| 02/26/2009 | US20090053728 Analytical Method and Kit |
| 02/26/2009 | US20090053723 Peripherin and Neurofilament Light Protein Splice Variants in Amyotrophic Lateral Sclerosis (ALS) |
| 02/26/2009 | US20090053702 Specific and universal probes and amplification primers to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories |
| 02/26/2009 | US20090053701 Detectable nucleic acid tag |
| 02/26/2009 | US20090053700 Optical sorting method |
| 02/26/2009 | US20090053697 Pharmacological Applications of Mitochondrial DNA Assays |
| 02/26/2009 | US20090053695 Gene Marker and Use Thereof |
| 02/26/2009 | US20090053692 Detection of hiv-1 by nucleic acid amplification |
| 02/26/2009 | US20090053362 Novel upases and uses thereof |
| 02/26/2009 | US20090053360 Gene encoding glycogen synthase and use thereof |
| 02/26/2009 | US20090053359 Ammonia transporter gene and use thereof |
| 02/26/2009 | US20090053358 Sulfate Ion Transporter Gene and Use Thereof |
| 02/26/2009 | US20090053300 Monoclonal antibody, gene encoding the antibody, hybridoma, pharmaceutical composition, and diagnostic reagent |
| 02/26/2009 | US20090053298 constitutive active/androstane receptor (CAR); antisense agents; drug screening; hepatocytes |
| 02/26/2009 | US20090053296 Using cell-mediated immune response to e6 and e7 peptides as diagnostic/prognostic indication of recurrence and/or development of cervical intraepithelial neoplasia (CIN) |
| 02/26/2009 | US20090053295 Regulatable fusion promoters |
| 02/26/2009 | US20090053292 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof |
| 02/26/2009 | US20090053265 Antigenic peptides and their use |
| 02/26/2009 | US20090053264 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
| 02/26/2009 | US20090053256 inducing an immune response to a poxvirus in a mammal by administering a composition comprising a nucleic acid molecule comprising nucleotide sequence encoding a variola F8 polypeptide, wherein nucleotide sequence is codon optimized for expression in both a mammalian cell and a bacterial cell |
| 02/26/2009 | US20090053255 Anti-arthropod vector vaccines, methods of selecting and uses thereof |
| 02/26/2009 | US20090053254 Recombinant human alpha-fetoprotein as an immunosuppressive agent |
| 02/26/2009 | US20090053252 Bimer or an oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins |
| 02/26/2009 | US20090053248 Compositions and methods for transepithelial molecular transport |
| 02/26/2009 | US20090053243 Anti-IgSF4 Antibody and Utilization of the Same |
| 02/26/2009 | US20090053241 inhibition of platelet derived growth factor receptor-beta (PDGFR beta ) on angiogenesis, and provides for treatment of angiogenesis; |
| 02/26/2009 | US20090053240 Novel Immunoglobulin Insertions, Deletions and Substitutions |
| 02/26/2009 | US20090053234 Methods of Preventing or Treating Inflammatory or Autoimmune Disorders by Administering Integrin ALPHAVBETA3 Antogonists in Combination with other Prophylactic or Therapeutic Agents |
| 02/26/2009 | US20090053233 Cytotoxic Antibody Directed Against Type B Lymphoid Hematopoietic Proliferations |
| 02/26/2009 | US20090053231 Optical Disc Apparatus |
| 02/26/2009 | US20090053230 Anti-ox40l antibodies and methods using same |
| 02/26/2009 | US20090053228 Lawsonia intracellularis subunit vaccines |
| 02/26/2009 | US20090053225 Recombinant antibodies against cd55 and cd59 and uses thereof |
| 02/26/2009 | US20090053214 Antibodies to myelin associated glycoprotein (MAG); neurological diseases/disorders |
| 02/26/2009 | US20090053213 for inflammatory diseases such as rheumatoid arthritis; GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor); |
| 02/26/2009 | US20090053212 Humanized anti-human osteopontin antibody |
| 02/26/2009 | US20090053203 Chimeric metal binding protein for use in prevention and treatment of cancer, diabetes, obesity, cardiovascular, metabolic, neurodegenerative, gastrointestinal, autoimmune, rheumatological and infectious diseases; drug delivery |
| 02/26/2009 | US20090053201 Using variation in DNA polymerase sequence as diagnostic indicator of adefovir or tenofovir resistance in virus; viricides |
| 02/26/2009 | US20090053196 Chn-1/Chip-Antagonists For The Treatment Of Muscular Diseases |
| 02/26/2009 | US20090053191 Phospholipases, nucleic acids encoding them and methods for making and using them |
| 02/26/2009 | US20090053186 Therapy for primary and metastatic cancers |
| 02/26/2009 | US20090053185 Coagulation factor x polypeptides with modified activation properties |
| 02/26/2009 | US20090053184 Compositions comprising t cell receptors and methods of use thereof |
| 02/26/2009 | US20090053178 Use of herpes vectors for tumor therapy |
| 02/26/2009 | US20090053173 Stabilization of such as human interleukin 11; reduced toxicity; cost effective; shelf life; SARS virus, HIV, HCV, HBV, or HAV, and the cancer diseases, such as leukemia and malignant melanoma; between a human serum albumin and an Interferon |
| 02/26/2009 | US20090053147 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
| 02/26/2009 | US20090053145 Anti-viral compositions and methods of use in cattle |
| 02/26/2009 | US20090050136 Transgenic plant cells and plants having modified activity of the gbssi and of the be protein |
| 02/26/2009 | DE102005011003B9 Verfahren und Mittel zur differentiellen Diagnose von Schilddrüsentumoren Method and means for the differential diagnosis of thyroid tumors |
| 02/26/2009 | CA2734549A1 Anti-idiotypic antibodies which neutralise the inhibitory activity of an inhibitory antibody directed against the c1 domain of factor viii |
| 02/26/2009 | CA2713185A1 Cationic alpha-amino acid-containing biodegradable polymer gene transfer compositions |
| 02/26/2009 | CA2700463A1 Use of eif-5a1 sirna to protect islets cells from apoptosis and to preserve their functionality |
| 02/26/2009 | CA2697294A1 Interaction screening methods, systems and devices |
| 02/26/2009 | CA2697282A1 Pvii phage display |
| 02/26/2009 | CA2697252A1 Calmodulin-binding peptides that reduce cell proliferation in cancer and smooth muscle proliferation diseases |
| 02/26/2009 | CA2697055A1 Methods and compositions for post-transcriptional gene silencing |
| 02/26/2009 | CA2696864A1 New proteins for use in human and animal staphylococcus infections |
| 02/26/2009 | CA2696701A1 Cdca1 peptide and pharmaceutical agent comprising the same |
| 02/26/2009 | CA2696691A1 Hypoallergenic molecules |
| 02/26/2009 | CA2696684A1 Pthrp, its isoforms and antagonist thereto in the diagnosis and treatment of disease |
| 02/26/2009 | CA2696591A1 Cdh3 peptide and medicinal agent comprising the same |
| 02/26/2009 | CA2696363A1 Method for purifying or detecting a target protein |
| 02/26/2009 | CA2695674A1 Metabolomic profiling of prostate cancer |
| 02/26/2009 | CA2695484A1 Production method |
| 02/26/2009 | CA2694476A1 Permissive cells and uses thereof |
| 02/26/2009 | CA2694364A1 Improved methods for the formation of disulphide bonds |
| 02/25/2009 | EP2028493A1 Procalcitonin 3-116 |
| 02/25/2009 | EP2028278A1 RNA sequence-specific mediators of RNA interference |
| 02/25/2009 | EP2028275A2 Protein glycosylation modification in pichia pastoris |
| 02/25/2009 | EP2028274A2 An antisense oligonucleotide against the TGF-beta2 gene |
| 02/25/2009 | EP2028273A1 Method for detecting uro-genital infection, oligonucleotide, oligonucleotide combination, biochip and a set based thereon |
| 02/25/2009 | EP2028272A1 Method of modifying nucleotide chain |
| 02/25/2009 | EP2028271A1 New proteins for use in human and animal staphylococcus infections |
| 02/25/2009 | EP2028270A2 Modified recombinant vaccina viruses and uses thereof |
| 02/25/2009 | EP2028269A1 Differentiation of non-insulin producing cells into insulin producing cells by GLP-1 or Exendin-4 and uses thereof |
| 02/25/2009 | EP2028266A1 Method of producing lymphocytes |
| 02/25/2009 | EP2028193A1 Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regions |
| 02/25/2009 | EP2028190A1 Compounds and methods for therapy and diagnosis of lung cancer |
| 02/25/2009 | EP2028188A1 Hypoallergenic molecules |
| 02/25/2009 | EP2028187A1 Human and mouse targeting peptides identified by phage display |
| 02/25/2009 | EP2028186A2 Hepatitis C inhibitor tri-peptides |
| 02/25/2009 | EP2027889A1 New neuronal viability factor and use thereof |
| 02/25/2009 | EP2027874A2 Methods of administering/dosing anti-rsv antibodies for prophylaxis and treatment |
| 02/25/2009 | EP2027296A2 Compositions and methods for detection and modulation of t cell mediated immune responses against viral vectors utilized for gene therapy |
| 02/25/2009 | EP2027276A2 Antifungal polypeptides |
| 02/25/2009 | EP2027275A2 Use of non-agrobacterium bacterial species for plant transformation |
| 02/25/2009 | EP2027274A1 Modified vird2 protein and its use in improved gene transfer |
| 02/25/2009 | EP2027273A1 Polypeptide producing cells |